IJCRR - Vol 09 issue 10 current issue , May, 2017
Detection of Carbapenem-Resistant Klebsiella Pneumoniae Isolates from Clinical Specimens in Nnamdi Azikiwe University Teaching Hospital, Nnewi
Author: Onukwube Cyril Chinedu, Agbakoba Nneka Regina, Egwuatu Chukwudi Charles, Aghanya Iloduba Nnaemeka
Background: Carbapenem-resistant Klebsiella pneumoniae is emerging rapidly worldwide. The accurate and prompt identification of Klebsiella pneumoniae carbapenemase (KPC) is a key to limiting the spread of these bacteria. Increasingly, Klebsiella bacteria have developed antibiotic resistance most recently to the class of antibiotics known as carbapenems.
Aim: The study was done to detect carbapenem-resistant Klebsiella pneumonia isolates from clinical specimens in Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria.
Methodology: K. pneumoniae clinical isolates were collected and processed at Nnamdi Azikiwe University Teaching Hospital Medical Microbiology and Parasitology laboratory from August 2012 to February 2013. Fifty-two Klebsiella pneumoniae recovered from different specimens namely; wound swabs (14), urine (26), sputum (7), and endocervical swab/high vaginal swab (5) were analyzed. Antimicrobial susceptibility testing (AST) was determined by agar disc diffusion method using Mueller-Hinton agar according to Clinical and Laboratory Standards Institute recommendations. Modified Hodge test (MHT) was carried out on clinical isolates that showed reduced disc sizes to carbapenem and resistant to the third generation cephalosporin. Polymerase chain reaction (PCR) was carried out to detect the presence of blaKPC gene. Results: Antibiotics susceptibility results revealed that meropenem and Imipenem showed the highest sensitivity (100%) against the isolates tested. Ertapenem showed 94.2% sensitivity. K. pneumoniae was isolated more from female patients 30(57.7%) than from male patients 22(42.3%). The result of the single PCR also revealed the absence of blaKPC gene. The PCR and MHT results showed strong consistency when compared.
Conclusion: Care must be taken in the prescription and administration of carbapenem as it is the last resort for many bacterial infection. Infection control policies should be strictly adhered to.
Keywords: K. Pneumonia, Antimicrobial susceptibility testing (AST), Parasitology, Carbapenem
Onukwube Cyril Chinedu, Agbakoba Nneka Regina, Egwuatu Chukwudi Charles, Aghanya Iloduba Nnaemeka. Detection of Carbapenem-Resistant Klebsiella Pneumoniae Isolates from Clinical Specimens in Nnamdi Azikiwe University Teaching Hospital, Nnewi International Journal of Current Research and Review. Vol 09 issue 10 current issue , May, 44-48
Alba, J., Ishii, Y., Thomson, K., Moland, E.S., and Yamaguchi, K. (2005). Kinetics study of KPC-3, a plasmid-encoded class A carbapenem-hydrolyzing β-lactamase. Antimicrobial Agents and Chemotherapy; 49: 4760-4762.
Bilavsky, E., Schwaber, M.J., and Carmeli, Y. (2010). How to stem the tide of carbapenemase-producing Enterobacteriaceae?: proactive versus reactive strategies. Current Opinion in Infectious Diseases; 23: 327-331.
Carvalhaes, C.G., Picao, R.C., Nicoletti, A.G., Xavier, D.E., and Gales, A.C. (2010). Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results. Journal of Antimicrobial Chemotherapy; 65: 249-251
Clinical and Laboratory Standards Institute (2009). Performance standards for antimicrobial susceptibility testing; Nineteenth Informational Supplement. CLSI Document M100- S19. Wayne, PA: Clinical and Laboratory Standards Institute.
Cortés, G., Borrell, N., De-astorza, B., Gómez, C., Sauleda, J., and Albertí, S. (2002). "Molecular Analysis of the Contribution of the Capsular Polysaccharide and the Lipopolysaccharide O Side Chain to the Virulence of Klebsiella pneumoniae in a Murine Model of Pneumonia". Infection and Immunity; 70(5): 2583-2590.
Hirsch, B., and Tam, V.H. (2010). Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug infection. Journal of antimicrobial chemotherapy; 65: 1119-1125.
Iroha, I.R., Oji, A.E., and Ayogu, T.E. (2011). Analysis of Antibiotic susceptibility of Klebsiella pneumoniae strains isolated from different clinical specimens in Enugu state. International Journal of Current Research; 2(1): 8-14.
Jumbo, G.T.A., Emanghe, U.E., Akpan, S., and Bolarin, D.M. (2011). Klebsiella infections and Antimicrobial susceptibility patterns in the 21st century: A Paradigm shift. Asian journal of Pharmaceutical and Health Sciences; 1(4): 204-208.
LA county Department of Public Health (2010). Acute communicable disease control: carbapenem-resistant Klebsiella pneumoniae. Retrieved November 15, 2012 from http://www.publichealth.lacounty.gov/acd/Diseases/Klebsiella.htm
Lijun, W., Haitong, G., and Xinxin, L. (2012). A Rapid Low-cost Real-time PCR for the Detection of Klebsiella pneumoniae Carbapenemase Genes. Annals of Clinical Microbiology and Antimicrobials; 11(9): 1-6.
Martin, G.J., and Friedlander, A.M. (2010). Anthrax as an agent of bioterrorism. In: Mandell G.L., Bennett, J.E. and Dolin, R. editors. Mandell, Douglas, and Bennetts’s Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingstone Elsevier. 3983-3992.
Nordmann, P., Cuzon, G., and Naas, T. (2009). The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infection Disease; 9: 228–236.
Podschun, R. and Ullmann, U. (1998). "Klebsiella spp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors". Clinical Microbiology Reviews; 11(4): 589-603.
Ryan, K.J. and Ray, C.G. (2004). Sherris Medical Microbiology (4th ed.). McGraw Hill.
Sarathbabu, R., Ramani, T.V., Bhaskara, R.K., and Supriya, P. (2012). Antibiotic susceptibility pattern of Klebsiella pneumoniae isolated from sputum, urine and pus samples. Journal of Pharmacy and Biological Sciences; 1(2): 4-9.
Smith, M., Hanson, E.N.D., Herrera, V.L., Black, J.A., Lockhart, T. J., Hossain, A., Johnson, J. A., Goering, R.V., and Thomson, K. S. (2003). Plasmid-mediated, carbapenem-hydrolysing β-lactamase, KPC-2, in Klebsiella pneumoniae isolates. Journal of Antimicrobial Chemotherapy; 51: 711-714.
Smith, S. (2010). "Deadly bacteria's foothold spurs study: Mass. specialists try to halt spread". Retrieved December 5, 2012, from http://www.boston.com/news/health/articles/2010/10/07/mass_specialists_to_study drug_resistant_germs_spread/
Tenover, F.C., Kalsi, R.K., and Williams, P.P. (2006). Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerging Infectious Diseases; 12: 1209-1213.
Wang, P., Chen, S., Guo, Y., Xiong, Z., Hu, F., Zhu, D., and Zhang, Y. (2011). Occurrence of false positive results for the detection of carbapenemases in carbapenemase-negative Escherichia coli and Klebsiella pneumoniae isolates. 6: 26356.
Woodford, N., Dallow, J.W., Hill, R.L., Palepou, M. F., Pike, R., Ward, M.E., Warner, M., and Livermore, D.M. (2007). Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory. International Journal of Antimicrobial Agents; 29: 456-459.